| 000 | 01689 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515113145.0 | ||
| 264 | 0 | _c20080918 | |
| 008 | 200809s 0 0 eng d | ||
| 022 | _a1432-0584 | ||
| 024 | 7 |
_a10.1007/s00277-008-0450-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMoyo, Victor | |
| 245 | 0 | 0 |
_aErythropoiesis-stimulating agents in the treatment of anemia in myelodysplastic syndromes: a meta-analysis. _h[electronic resource] |
| 260 |
_bAnnals of hematology _cJul 2008 |
||
| 300 |
_a527-36 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review; Systematic Review | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnemia _xdrug therapy |
| 650 | 0 | 4 |
_aAnemia, Refractory _xdrug therapy |
| 650 | 0 | 4 |
_aAnemia, Sideroblastic _xdrug therapy |
| 650 | 0 | 4 |
_aBlood Transfusion _xstatistics & numerical data |
| 650 | 0 | 4 | _aDarbepoetin alfa |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Evaluation |
| 650 | 0 | 4 | _aEpoetin Alfa |
| 650 | 0 | 4 |
_aErythropoiesis _xdrug effects |
| 650 | 0 | 4 |
_aErythropoietin _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHematocrit |
| 650 | 0 | 4 |
_aHemoglobins _xanalysis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMyelodysplastic Syndromes _xcomplications |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aLefebvre, Patrick | |
| 700 | 1 | _aDuh, Mei Sheng | |
| 700 | 1 | _aYektashenas, Behin | |
| 700 | 1 | _aMundle, Suneel | |
| 773 | 0 |
_tAnnals of hematology _gvol. 87 _gno. 7 _gp. 527-36 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00277-008-0450-7 _zAvailable from publisher's website |
| 999 |
_c17852442 _d17852442 |
||